313TE targets IL-13Rα2-positive tumors in preclinical testing
A preclinical study reports that the IL-13E13Y-based T-cell engager 313TE linked IL-13Rα2-positive tumor cells to T cells, promoting receptor-dependent killing ...
Tag: 313TE
POPULAR NEWS
-
313TE targets IL-13Rα2-positive tumors in preclinical testing
-
DCT and high-boost filtering improve grayscale multi-focus fusion in four-dataset study
-
Retrospective study tests time-specific HCC recurrence prediction after ablation
-
Stoma patients describe telehealth benefits for product and skin care